Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
Today, a brief rundown of news involving the Food and Drug Administration and Takeda, as well as updates from BeOne Medicines, AstraZeneca and Alumis that you may have missed. More than 300 biotechnology executives, investors and patient advocates have …